You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

NIACOR Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Niacor, and what generic alternatives are available?

Niacor is a drug marketed by Avondale Pharms and is included in one NDA.

The generic ingredient in NIACOR is niacin. There are fourteen drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the niacin profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Niacor

A generic version of NIACOR was approved as niacin by BARR on April 14th, 2005.

  Subscribe

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for NIACOR?
  • What are the global sales for NIACOR?
  • What is Average Wholesale Price for NIACOR?
Drug patent expirations by year for NIACOR
Recent Clinical Trials for NIACOR

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of PennsylvaniaN/A
Heidelberg UniversityPhase 1

See all NIACOR clinical trials

Pharmacology for NIACOR
Drug ClassNicotinic Acid

US Patents and Regulatory Information for NIACOR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Avondale Pharms NIACOR niacin TABLET;ORAL 040378-001 May 3, 2000 RX No Yes ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

NIACOR Market Analysis and Financial Projection Experimental

Market Dynamics and Financial Trajectory for Niacin and Niacinamide: A Comprehensive Overview

Introduction to Niacin and Niacinamide

Niacin and niacinamide, forms of Vitamin B3, are crucial components in various industries, including healthcare, cosmetics, and food supplements. Understanding the market dynamics and financial trajectory of these compounds is essential for stakeholders looking to invest or expand in these sectors.

Global Market Size and Growth

The global niacin and niacinamide market has been experiencing significant growth. As of 2021, the market was valued at approximately USD 1.2 billion and is projected to reach USD 2.5 billion by 2032, growing at a Compound Annual Growth Rate (CAGR) of 5.2% during the forecast period from 2022 to 2032[1][4].

Key Drivers of Market Growth

Rising Awareness in Skincare

The increasing awareness and demand for skincare products, particularly those containing niacinamide, are major drivers of market growth. Niacinamide is highly valued for its ability to brighten the skin, reduce acne, and hydrate, making it a preferred ingredient in beauty treatments[1].

Health Supplements and Pharmaceutical Applications

The use of niacin and niacinamide in health supplements and pharmaceuticals is another significant factor. These compounds help maintain vitamin B3 and cholesterol levels, enhance energy metabolism, and reduce the risk of chronic diseases such as cancer and heart disease. This has led to a surge in demand for these products in the health and wellness sector[1][4].

Influence of Social Media and Influencer Marketing

The growing penetration of social media and the impact of influencer marketing have also contributed to the increased demand for niacin and niacinamide products. Social media platforms have become powerful tools for promoting skincare and health supplements, driving consumer interest and purchases[1].

Regional Market Dynamics

USA

The USA is a key market for niacin and niacinamide, driven by the presence of numerous pharmaceutical and cosmeceutical companies. The rising prevalence of conditions such as downer cow syndrome in dairy animals and pediatric obesity further fuels the demand for these products in the region[1].

India

India is an emerging market, accounting for a significant share of the global niacin and niacinamide market. The rapid development of chemical studies and the increasing healthcare costs in India are expected to drive lucrative growth opportunities in this region. India is also becoming a prominent R&D hub for pharmaceutical manufacturers[1].

China

China leads the East Asia market with a notable share. The acceptance of niacin and niacinamide for skin rejuvenation and the rising demand for these compounds to address vitamin deficiencies are key factors driving growth in this region[1].

Distribution Channels

Pharmacies and drug stores dominate the distribution channels for niacin and niacinamide, holding around 64.5% of the market share in 2021. These channels are widely adopted for self-prescribed drugs and skincare products[1].

Competitive Landscape

The market is characterized by the presence of several key players, including Lonza, Koninklijke, Bactolac, Merck, BASF, Foodchem, Evonik, Jubilant, Vertellus Specialties, Fagron, and Zhejiang NHU. These companies are focusing on introducing innovative solutions, obtaining regulatory approvals, and engaging in mergers and acquisitions to expand their product offerings[1][4].

Financial Trajectory

Historical Growth

From 2015 to 2021, the niacin and niacinamide market grew at a CAGR of 5.3%, indicating a steady and robust expansion[1].

Future Projections

The market is expected to continue its upward trend, with projections indicating a growth to USD 2.36 billion by 2032 at a CAGR of 3.3% to 5.2% depending on the source[1][4].

Challenges and Opportunities

Regulatory Environment

The market is subject to various regulatory frameworks, particularly in the pharmaceutical sector. Companies must navigate these regulations to obtain approvals and maintain compliance, which can be both a challenge and an opportunity for growth through innovation and compliance[5].

Consumer Demand and Awareness

Increasing consumer awareness about the health benefits of niacin and niacinamide presents a significant opportunity for market growth. However, it also poses a challenge in terms of meeting the rising demand with high-quality products[1].

Key Takeaways

  • The global niacin and niacinamide market is expected to grow significantly, driven by increasing demand in skincare, health supplements, and pharmaceutical applications.
  • Key regions include the USA, India, and China, each with unique market dynamics.
  • The distribution channel is dominated by pharmacies and drug stores.
  • Major players are focusing on innovation, regulatory approvals, and strategic expansions.
  • The market is projected to reach USD 2.5 billion by 2032 with a CAGR of 5.2%.

Frequently Asked Questions

What is the projected market size of the niacin and niacinamide market by 2032?

The global niacin and niacinamide market is projected to reach USD 2.36 billion to USD 2.5 billion by 2032[1][4].

What is the expected CAGR of the niacin and niacinamide market?

The market is expected to exhibit a CAGR of 3.3% to 5.2% from 2022 to 2032[1][4].

What are the primary drivers of the niacin and niacinamide market growth?

The primary drivers include rising awareness in skincare, increasing use in health supplements and pharmaceutical applications, and the influence of social media and influencer marketing[1][4].

Which regions are leading the niacin and niacinamide market?

The leading regions include the USA, India, China, Japan, and Germany[1].

Who are the key players in the niacin and niacinamide market?

Key players include Lonza, Koninklijke, Bactolac, Merck, BASF, Foodchem, Evonik, Jubilant, Vertellus Specialties, Fagron, and Zhejiang NHU[1][4].

Cited Sources

  1. Future Market Insights: Niacin and Niacinamide Market Size, Share, Outlook & Trend - 2032.
  2. Oregon Drug Use Review / Pharmacy & Therapeutics Committee: Meeting Docs.
  3. Precedence Research: Lipid-lowering Drugs Market Size to Hit USD 46.58 Bn by 2033.
  4. Business Research Insights: Niacin & Niacinamide Market Size, Share | 2032.
  5. Federal Trade Commission: Public Record Version - Commission Opinion.

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.